UVEAL MELANOMA, RECURRENT
Clinical trials for UVEAL MELANOMA, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, RECURRENT trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New tumor injection shows promise for advanced cancers
Disease control Recruiting nowThis early-stage trial tests a new drug, ONM-501, injected directly into tumors, either alone or with another drug (cemiplimab), for people with advanced solid tumors or lymphomas that have not responded to other treatments. The study aims to find the safest dose and check for si…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New pill shows promise for rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX for people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink tumors or slow the cancer. About…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated May 01, 2026 15:59 UTC